Enliven Therapeutics Appoints Kristine Ball to Board of Directors

Bitget2026/10/14 20:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Enliven Therapeutics appointed Kristine Ball to its board, effective immediately, on Oct. 14, 2026.
Ball brings more than 20 years of executive experience, including CEO roles at Antiva Biosciences and Soteria Biotherapeutics.
Her background includes serving as Relypsa's chief financial officer, helping guide its transition from clinical development to commercial operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enliven Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610141630PR_NEWS_USPR_____LA72291) on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Enliven Therapeutics Appoints Kristine Ball to Board of Directors

You may also like

Crypto prices